Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

• Status: Completed
• Trial end date: 2021-10-19
• Target enrollment: 0
• Participant gender: All

Summary

Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Visus Therapeutics
• Treatments: Brimonidine Tartrate; Carbachol

Criteria

Inclusion Criteria:

• Male or female in good general health

• Must have presbyopia

Exclusion Criteria:

• History of allergic reaction to the study drug or any of its components

• Any disease or medical condition that, in the opinion of the Investigator, would prevent the subject from participating in the study or might confound study results